Encephalitis

Review Article

December 21, 2020

Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis

Soon-Tae Lee

encephalitis. 2021;1(1):4-6.

N-methyl-D-aspartate receptor encephalitis (NMDAR encephalitis) needs both precise immunotherapy and symptomatic treatments. Medical and procedural interventions are available for seizure, psychosis, dyskinesia, hypersalivation, and autonomic dysfunction. This perspective shares the experience for the symptomatic care of NMDAR encephalitis.

Original Article

December 4, 2020

Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study

Sang Bin Hong, Yong-Won Shin, Jangsup Moon, et al.

encephalitis. 2021;1(1):7-13.

CSF oligoclonal bands in anti-NMDA-receptor encephalitis associate with a deteriorating clinical course leading to prolonged hospital stays and a poorer outcome at 1 year, suggesting that initial CSF oligoclonal band testing may aid in identifying patients with unfavorable disease course.

Original Article

December 22, 2020

Respiratory virus-related meningoencephalitis in adults

Seon-Jae Ahn, Jangsup Moon, Jun-Sang Sunwoo, et al.

encephalitis. 2021;1(1):14-19.

The respiratory virus is one of the causative pathogens of central nervous system infection, but it has not been noticed in adults. Ahn et al. showed 10 cases of respiratory virus related meningoencephalitis with retrospective review of the neurological infection registry.

Case Report

December 24, 2020

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil

Sungeun Hwang, Hyoshin Son, Jangsup Moon, et al.

encephalitis. 2021;1(1):20-24.

Neuro-Sweet disease is one of rare causes of recurrent aseptic meningoencephalitis. Hwang et al. present a case of 51-year-old male with recurrent encephalitis who was successfully treated with tocilizumab and mycophenolate mofetil.

Case Report

December 23, 2020

Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis

Yoonhyuk Jang, Jeong-Min Kim, Jangsup Moon, et al.

encephalitis. 2021;1(1):25-29.

Jang et al. report a rare case of a 32-year-old man with N-methyl-D-aspartate receptor (NMDAR)-encephalitis detected after eight years by serial HSV-1 and HHV-7 encephalitis. This report aids our knowledge about the clinical manifestation and treatment of rare HHV-7 encephalitis and suggests that NMDAR-encephalitis should be vigilantly monitored in patients with a history of herpes virus encephalitis.

Current Issue: Volume 1(1); Jan 2021

Volume 1, No. 1

Online ISSN: 2734-1461

MOST VIEWED MOST CITED

471	Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
278	Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study
252	Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
191	Respiratory virus-related meningoencephalitis in adults
185	Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis

Editorial Office: 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
Tel: +82-2-2072-0629 Fax: +82-2-765-7920 E-mail: editor@encephalitisjournal.org

Copyright © 2021 by Korean Encephalitis and Neuroinflammation Society. All rights reserved.

prev

next

prev

next